首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献，搜索用时 31 毫秒
1.
The antimicrobial enrofloxacin (Baytril®, Bayer) was evaluated under field conditions in the winter months for treatment of clinical Aeromonas salmonicida infections in salmonids by feeding medicated diets. Two trials in which lake trout Salvelinus namaycush were treated with enrofloxacin at 10mg/kg per d for 10d resulted in reduced mortalities when compared to non-medicated controls. A third trial in which Atlantic salmon Salmo salar were treated required 20d for the fish to consume the 10d medicated ration, due to poor feeding. This resulted in an effective dose of 5mg/kg per d for 20d. In spite of the lower feeding activity, a reduction in mortalities in medicated fish was observed. Tissue concentrations of drug were in excess of minimum inhibitory concentrations of the drug for the A. salmonicida isolates tested.  相似文献   

2.
Abstract An outbreak of furunculosis was diagnosed in an Atlantic salmon, Salmo salar L., commercial sea-pen farm and treated with the fluoroquinolone antimicrobial enrofloxacin. The affected post-smolt, adult fish and broodstock readily consumed pelleted feed impregnated with enrofloxacin at concentrations of 1000, 1300 and 2000ppm, respectively, daily for 10 days. Mortalities of infected post-smolts were reduced from an average of 5.8% per month for the 2 months preceding therapy to 0.6% per month for the 2 months following therapy. Infected adult fish had a 2 month mean mortality rate of 2.6% prior to enrofloxacin treatment and 0.3% over the 2 months subsequent to therapy. Apparently noninfected (nonclinical) fish in the same farm exhibited an average monthly mortality of 0.4% over the 4-month study period. Sea water temperatures gradually rose from less than 2°C in March to approximately 12°C in September. Mean antimicrobial tissue concentrations over the 10 complete days of medication were 4.58, 7.32, 4.58, 8.89 and 3.40ppm for muscle, skin plus fat, liver, kidney and gill, respectively. Within 24h of consuming medicated feed, tissue concentrations of antimicrobial were nearly 66% of the average concentrations for the medication period. Half-lives of elimination for the antimicrobial residues were approximately 2 days for liver, 3 days for kidney, 6 days for gill, 11 days for muscle and 22 days for skin plus fat. The producers reported a successful harvest after a 180-day medication-free period.  相似文献   

3.
Streptococcal infection ( Streptococcus iniae ) was diagnosed sequentially in two tanks of hybrid striped bass Morone saxatilis male × M. chrysops female (Sunshine bass) grown in a commercial freshwater recirculation facility in western Massachusetts. The pathogen was isolated in the laboratory, biochemically and morphologically characterized, and antibacterial sensitivities determined. Streptococcus iniae -induced lesions in the Sunshine bass were character at the gross and histopathological levels. Initial treatment with oxytetracycline was unsuccessful. Based on sensitivity results, enrofloxacin-medicated feed was dosed at 10 mg/kg body weight for 10 d, while a subsequent trial was conducted at 5 mg/kg body weight for 10 d. Mortality of fish subsided promptly following initiation of enrofloxacin therapy, yielding a final mortality in the initial tank of 10.83% (control tank 55.5%) and in the second tank of 16.97% (control tank 39.8%). Tissue enrofloxacin residues, detected via a microbiologic bioassay, revealed greater quantities and longer duration of residues in various tissues from the 5-mg as compared to the 10-mg trial, potentially the result of adverse feed palatability. Enrofloxacin appears to have excellent potential as an antibacterial agent for treating susceptible bacterial diseases of Sunshine bass.  相似文献   

4.
This study was performed to determine the efficacy of orally administered florfenicol in the treatment of experimentally induced vibriosis (Listonella anguillarum) in cod, Gadus morhua. The L. anguillarum strain HI-610 was used. This strain has a minimal inhibitory concentration value of 0.5 mg L(-1) against florfenicol. Fifteen groups of 40 fish each were challenged by bath with 1.7 x 10(5) CFU mL(-1) for 1 h. Three days following challenge, medication with florfenicol was introduced in 12 of the groups. The dosages used were 10 mg kg(-1) day(-1) for 10 consecutive days in marine or salmonid pellets, 10 mg kg(-1) day(-1) for five consecutive days in marine pellets or administered at days 1, 2, 4, 6 and 8 following initiation of treatment. Among challenged unmedicated fish mortality started at day 3 post-challenge reaching a final cumulative mortality of 77% at day 15. The experiment was terminated at day 26. In the medicated groups, the majority of deaths occurred from days 3-7 post-challenge reaching final cumulative mortalities of 31% and 52%, respectively, for the fish given marine and salmonid pellets for 10 consecutive days. The fish treated with medicated marine pellets for five consecutive days and at days 1, 2, 4, 6 and 8 (sequential feeding) following initiation of treatment had cumulative mortalities of 52% and 38%, respectively. Survival of medicated fish in all groups was significantly (P < 0.005) greater than survival of challenged unmedicated fish. Furthermore, a significant difference (P < 0.001) in survival was found between fish treated for 10 consecutive days using marine pellets and the groups using marine pellets for five consecutive days and salmonid pellets for 10 consecutive days. Twenty four hours following last medication, six fish had mean plasma concentrations of 3.3 +/- 1.7 and 3.5 +/- 2.8 microg mL(-1), respectively, in fish treated for 10 consecutive days using marine and salmonid pellets. Corresponding values for fish treated for five consecutive days and by sequential feeding were 2.2 +/- 2.3 and 1.7 +/- 0.7 microg mL(-1), respectively.  相似文献   

5.
Two controlled feeding trials were conducted in which Terramycin and/or Romet-30 were incorporated into either semipurified or practical diets to provide 25, 50 and 100% of the recommended dosages when fed to juvenile channel catfish at 3% of body weight per day. Data for 4-wk and 8-wk weight gain, feed efficiency, and survival of channel catfish fed the various diets were analyzed to determine if these responses could be enhanced by dietary inclusion of either or both antibiotics. In addition, 4-wk and 8-wk muscle samples from fish of each dietary treatment were analyzed by high performance liquid chromatography for oxytetracycline (OTC), ormetoprim (OMP) and sulfadimethoxine (SDM) residues. The performance of juvenile channel catfish was not enhanced by the inclusion of Romet-30 or Terramycin in semipurified or practical diets. Moreover, fish performance tended to decrease relative to that of fish fed the control diet when antibiotics were supplemented in the diet. Residues of OTC, OMP and SDM in the fillets of catfish fed medicated diets generally increased in a time- and dose-dependent fashion. Residue concentrations above the legal tolerance limit of 0.1 mg/kg were noted in most samples from fish fed diets medicated at 100% of recommended levels and in many of the samples from fish subjected to lesser dosages, particularly in those that had been fed diets with Romet-30. Allowing catfish that were previously fed medicated diets a 3-wk or 4-wk withdrawal period effectively decreased the OTC, OMP and SDM contents of fillets to undetectable levels.  相似文献   

6.
A feeding trial was conducted to evaluate the dietary copper requirement of red drum (Sciaenops ocellatus) and compare the bioavailability of copper sulphate (CuSO4) and copper‐ethanolamine. A basal diet was formulated using semi‐purified ingredients and analysed to contain 3 mg Cu/kg. Both copper sources were supplemented to the basal diet at either 5, 10 or 20 mg Cu/kg of dry diet. No significant differences were observed in growth performance of fish fed the various diets. However, red drum fed all copper‐supplemented diets retained more copper in liver and whole‐body tissues compared to fish fed the basal diet. Within both inorganic and organic copper treatments, the highest tissue copper concentrations were observed in fish fed diets supplemented with 10 mg Cu/kg. No significant differences were detected in net copper retention regardless of the nature of the copper source; hence, the bioavailability of copper sulphate and copper‐ethanolamine complex was not different in the diets for juvenile red drum. Furthermore, the minimum copper requirement for growth performance of juvenile red drum appeared to be satisfied when fish were fed the basal diet containing 3 mg Cu/kg diet, and no detrimental effects were observed in red drum fed diets supplemented with 20 mg Cu/kg.  相似文献   

7.
采用液相色谱-三重四级杆复合线性离子阱质谱(HPLC/Q-TRAP MS),在正离子检测模式下,对鲤鱼(Cyprinus carpio)腹腔注射恩诺沙星给药后肝脏中的代谢产物进行分析.根据保留时间和各色谱峰质谱裂解规律,推测了恩诺沙星在鲤鱼肝脏中的代谢产物,同时,根据二级质谱碎片离子推测代谢途径及代谢产物结构.结果显示,恩诺沙星进入鲤鱼肝脏后,除以恩诺沙星原形药物(M0)和N-去乙基代谢产物环丙沙星(M2)形式存在外,还有少量恩诺沙星脱羧代谢产物(M1)和恩诺沙星羟基化代谢产物(M3-1和M3-2).该研究可为深入了解恩诺沙星在水生动物体内代谢产物及代谢机理提供理论基础,为在水产养殖生产中科学、合理地使用恩诺沙星提供参考.  相似文献   

8.
The duration of efficacy of emamectin benzoate in the control of Caligus curtus infestations in Atlantic cod, Gadus morhua L., was studied following an administration of 50 μg kg?1 for seven consecutive days. No lice were found on medicated fish when challenged 1 week (challenge 1) or 5 weeks (challenge 2) following termination of medication, whereas the mean abundance of lice among the unmedicated fish was 17.9 and 19.3 lice per fish in challenge 1 and 2, respectively. Muscle concentrations of 19.5 ± 8.2 ng g?1 and 3.4 ± 0.9 ng g?1, respectively, and skin concentrations of 23.1 ± 10.8 and 4.2 ± 1.0 ng g?1, respectively, were found 27 and 55 days following the termination of medication. Tissue concentrations and the duration of efficacy indicate a dosing regime for emamectin in cod, similar to the regime used for Atlantic salmon, Salmo salar L.  相似文献   

9.
A field study to assess the efficacy of florfenicol (FFC) against enteric septicemia of catfish (ESC) was conducted with pond‐reared channel catfish fingerlings held in 0.1‐acre earthen ponds. Fish were challenged with Edwardsiella ictaluri in a natural pond outbreak or by cohabitation with E. ictaluri‐infected fish held in netpens. Fourteen ponds were assigned in equal number to two treatment groups, that is, either treated (with 10 mg FFC/kg body weight in medicated feed) or not treated (control) for 10 consecutive d. The threshold for enrollment into the study was 0.3% cumulative mortality attributed to ESC. Treatment was initiated on different dates for each pond because each pond was enrolled when 33 fish/pond were diagnosed with ESC based on clinical signs, lesions, or positive cultures. Mortality was monitored during the 10‐d treatment period and during a 14‐d posttreatment observation period. At the end of the 14‐d posttreatment observation period, all fish were euthanized, and 20 fish from each pond were examined by gross necropsy and evaluated for the presence of E. ictaluri by bacterial culture. The odds of a mortality in the control group were 2.20 times the odds of a mortality in the FFC‐treated group. Significantly fewer (P≤ 0.05) FFC‐medicated catfish died in comparison to unmedicated catfish. The minimum inhibitory concentration of FFC for this strain of E. ictaluri was 0.25 μg/mL in all fish that were assayed. The mean zone of inhibition (Kirby Bauer) was 36.8 mm from E. ictaluri isolates of test fish. There were no FFC treatment‐related lesions seen on gross pathology. FFC was efficacious and safe for control of mortality from E. ictaluri infection in catfish.  相似文献   

10.
Hybrid striped bass ( Morose saxatilis male × M. chrysops female) were injected with 25 and 50 mg oxytetracycline (OTC) per kg of fish. Rate of elimination of OTC from muscle tissue and inhibition of bacteria by muscle injected with OTC were studied. OTC residue in muscle of fish injected with 50 mg OTC/kg fish was much higher (P < 0.01) than that in fish injected with 25 mg/kg and took a longer time to clear from the muscle. In fish injected at 25 mg OTC/kg of fish, OTC was completely eliminated from muscle in 24 d; the rate of elimination constant (β) was 0.278/day and the half-life (t1/2) 2.5 d. In fish injected at 50 mg OTC/kg of fish, the OTC was not depleted in fish muscle until 32 d after injection; the rate of elimination constant 13 was 0.265/day and the half-life was 2.6 d. No statistical difference was found in muscle OTC residue between male and female fish. Size of fish (16.5 to 21.5 cm and 21.6 to 25.5 cm) made little difference in OTC residue in muscle. Muscle removed from fish injected with 25 mg/kg OTC 12 d after injection inhibited the growth of Vibrio anguillarum, V. ordalii and Aeromonas hydrophila in cultures.  相似文献   

11.
The present study was designed to explore pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin in healthy and Vibrio alginolyticus-infected large yellow croaker (Pseudosciaena crocea) after a single 10 mg/kg oral dose. Concentrations of enrofloxacin and ciprofloxacin in serum, liver, kidney, muscle and skin of fish were determined using high-performance liquid chromatography. Pharmacokinetic parameters were analysed based on classical compartmental model analysis. The overall changes in enrofloxacin concentration–time curves in serum and tissues of diseased fish were similar to those of healthy fish. However, the peak concentration and peak time of enrofloxacin in serum and tissues were different in healthy and diseased fish. A delay of enrofloxacin peak time in serum and all tissues appeared in the diseased fish. The peak concentrations in serum and tissues of the diseased fish were lower than those of healthy fish. In healthy fish, the area under the concentration–time curve (AUC) was in the order serum >liver > kidney >muscle > skin, while AUC was serum >live > muscle >kidney > skin in the diseased fish. The peak concentrations of ciprofloxacin in the liver, serum, kidney, muscle and skin of healthy fish were 0.93 μg/g, 0.55 μg/ml, 0.36 μg/g, 0.37 μg/g and 0.12 μg/g respectively. Tmax of ciprofloxacin in the corresponding tissues was 8, 24, 12, 12 and 16 h respectively. In the diseased fish, the peak concentrations of ciprofloxacin in the corresponding tissues were 0.52 μg/g, 0.52 μg/ml, 0.41 μg/g, 0.27 μg/g and 0.13 μg/g respectively. Tmax in the corresponding tissues were 0.5, 8, 12, 16 and 48 h respectively. These data indicate that the health status of fish affects drug absorption and metabolism.  相似文献   

12.
Two experiments were conducted to study the effects of feeding frequency on growth, and of handling stress on growth and mortality, in intensive tank culture of the walking catfish Clarias fuscus . In the first experiment, fish were grown from an initial weight of 37 g for 34 d. A fixed ration of 3.0% body weight per day was divided into either 1, 2, or 3 feedings per day, and fish were either handled weekly or left unhandled for the entire experiment. Fish given 3 feedings per day experienced 19% faster growth ( P < 0.05) than fish given the same ration in a single feeding per day. These differences in growth reflect differences in assimilation efficiency, assuming all other metabolic costs were constant among treatments. Handling of individuals caused decreased growth; however, there was no effect on mortality.
In the second experiment, fish were grown from an initial weight of 78 g for 29 d. Fish were fed either 1 or 2 satiation feedings per day and were either handled weekly or left unhandled for the entire experiment. Fish fed 2 satiation feedings per day experienced 47% faster growth ( P < 0.05) than fish fed 1 satiation feeding per day, which was assumed to reflect a higher level of food consumption. No effect of handling on either growth or mortality was observed for fish in experiment 2. Multiple meals per day also reduced depensatory growth among individuals in both experiments.  相似文献   

13.
Abstract. The efficacy of florfenicol against laboratory-induced infection with Aeromonas salmonicida was tested in Atlantic salmon, Salmo salar L., parr. Medication at three dose levels in the feed was started 24 h after bath challenge with A. salmonicida. The specific mortality rate in the unprotected infected control group was 75% compared with 5, 13 and 17% when florfenicol was given at dose levels of 20, 10 and 5 mg per kg body weight per day, respectively. Florfenicol was palatable to the fish at doses in excess of effective therapeutic levels and feeding for 10 days at 100 mg per kg, or for prolonged periods at 50 mg per kg and 10 mg per kg, resulted in no feeding problems or histopathological abnormalities. Florfenicol appears to have a good therapeutic index and considerable potential in the control of furunculosis in salmon.  相似文献   

14.
Semi‐purified, casein‐gelatin‐based diets were prepared and supplemented with quercetin (Q) and/ or ascorbic acid (AA): control diet C–Q–(100 mg/kg AA), diet C –Q+ (100 mg/kg AA + quercetin 10 g/kg), diet C +Q– (1000 mg/kg AA), and diet C +Q+ (1000 mg/kg AA + quercetin 10 g/kg). These diets were fed to tilapia for 19 wk and then fish were divided into controls and ultraviolet (UV) treatments. Fish were exposed to UV radiation. Control groups were protected with a MYLAR® polyester film and plexiglass. At week 20, the same fish were re‐exposed to UV radiation. Control groups of fish were protected by a double layer of MYLAR® and the UV groups were exposed with no protection. Before UV exposure, 24 h after, and 7 d after the second treatment, fish liver and skin were dissected for Q and AA analyses. The proportion of oxidized ascorbate was significantly increased in fish from treatments C –Q– and C –Q+ . Q concentrations in fish after exposures were negligible in skin, whereas liver concentrations were significantly different among control (34 ± 10 μg/g) and UV‐irradiated fish (11 ± 6 μg/g), respectively. The interaction between these two dietary antioxidants may change after chronic UV irradiation.  相似文献   

15.
Juvenile channel catfish were fed purified diets supplemented with magnesium (Mg) from Mg sulfate at levels of 0, 200, 400, 600, 800, and 1,000 mg/kg and 0, 200, 400, 600, and 800 mg/kg in two separate feeding studies. In study I, the effect of dietary levels of Mg on growth response, vertebral mineral content, and macrophage chemotaxis were evaluated. Study II had similar objectives except that whole body mineral content was measured, and resistance of channel catfish to Edwardsiella ictaluri challenge was also determined. Fish with an average weight of 10.89 g were stocked at a rate of 50 fish/110‐L aquarium (study I). In study II, fish with an average weight of 4.14 g were stocked at rates of 40 fish/110‐L aquarium. Prior to stocking, each batch of fish was acclimated to laboratory conditions and fed the basal diet for 2 wk. The concentration of Mg in rearing water was 1.8 mg/L. Each diet was fed to fish in quadruplicate and triplicate aquaria to apparent satiation for 10 wk for studies I and II, respectively. Fish fed the basal diet started to die as early as 3 d after the study began (17 d of feeding the diet without Mg supplementation). In both studies, weight gain, survival, and feed efficiency were lowest for fish fed the basal diet but increased with increasing dietary levels of Mg. However, the differences between the values of each of these parameters for fish fed diets containing supplemental Mg were not always significant. Magnesium‐deficiency signs observed were anorexia, sluggishness, convulsions, deformed snout, vertebral curvature, muscle flaccidity, and high mortality. Vertebral and whole body ash concentrations were high, but Mg content was low for fish fed the basal and the 200‐mg Mg diets. Bone Ca content did not differ among fish fed different diets (study I), but whole body Ca tended to increase for fish fed the basal diet, suggesting the possibility of calcification of soft tissues. Macrophage chemotaxis in the presence of exoantigen was highest for fish fed diets supplemented with Mg at 400 and 200 mgkg for studies I and II, respectively. When expressed in terms of chemotaxis index, however, maximum or near maximum value was observed at a dietary Mg level of 400 mg/kg. Thus, a dietary level of Mg of 400 mg/kg from Mg sulfate was required for optimum growth and survival, maintaining high tissue levels of Mg, prevention of muscle flaccidity and skeletal deformity, and stimulating macrophage chemotaxis. Dietary levels of Mg had no effect on the resistance of juvenile channel catfish to Edwarsiella. ictaluri challenge.  相似文献   

16.
周帅  胡琳琳  房文红  周凯  于慧娟 《水产学报》2011,35(8):1182-1190
采用高效液相色谱法,研究盐度33条件下恩诺沙星口灌和肌肉注射给药(剂量10 mg/kg)后,恩诺沙星及其代谢物环丙沙星在拟穴青蟹体内的药代动力学和组织分布。血淋巴和组织中药代动力学参数采用基于统计矩原理的非房室模型进行计算。恩诺沙星口灌和肌肉注射拟穴青蟹给药后,血药达峰快,分别为0.5 h和1 min,达峰浓度分别为12.90和31.86 μg/mL,曲线下面积(AUC)分别为216.1和816.8 μg/(mL·h)。恩诺沙星在拟穴青蟹组织中分布较广,口灌给药下肌肉和肝胰腺AUC分别为445.9和817.6 μg/(g·h),肌肉注射给药下的AUC分别为554.7和2 573.7 μg/(g·h)。与其它水产动物相比,恩诺沙星在拟穴青蟹体内消除速度为中等水平,口灌和肌肉注射恩诺沙星后血药消除半衰期(t1/2z)分别为26.45和57.02 h,总体清除率(CLz)分别为0.054和0.012 L/(h·kg)。恩诺沙星在拟穴青蟹体内代谢生成环丙沙星的量较少,口灌给药下血淋巴、肌肉和肝胰腺的AUCCIP/AUCENR分别为6.66%、3.66%和4.78%,肌肉注射给药下,其相应值分别为4.16%、7.24%和1.48%,在拟穴青蟹体内起药效作用仍是以恩诺沙星为主。以Cmax/MIC、AUC0-24/MIC评价恩诺沙星在青蟹体内的药效作用,建议给拟穴青蟹以10 mg/kg剂量每隔24小时投喂一次恩诺沙星,对弧菌引起的细菌性疾病具有较好的防治效果。  相似文献   

17.
Four trials were conducted with channel catfish, Ictalurus punctatus, under controlled laboratory conditions or in earthen ponds, to evaluate effects of dietary vitamin C concentration and feeding period on liver and anterior kidney vitamin C concentration. Clearance rate of vitamin C in liver and anterior kidney was also evaluated in unfed fish or fish fed a vitamin C-free diet. Results indicated that tissue vitamin C concentration is generally proportional to deitary vitamin C concentration, and that it may reach a maximum concentration within 2 weeks in fish fed diets containing vitamin C. Tissue vitamin C may be reduced to a minimum concentration within 2 weeks when fish were not fed or fed with a vitamin C-free diet at a high temprerature (31°). As temperature was reduced from 31 to 10°C there was a 44% and 13.6% drop in liver and anterior kidney vitamin C concentrations, respectively. At 10°C tissue vitamin C remained relatively constant (100 to 120 mg/g for liver, and 200 to 250 mg/g for anterior kidney) for at least 12 weeks if tissue vitamin C was saturated prior to reducing water temperature. Liver vitamin C appeared to be affected more dramatically by dietary vitamin C concentration and cleared more rapidly than anterior kidney during times of vitamin C deficiency.  相似文献   

18.
Two experiments were conducted in earthen ponds to evaluate the effect of dietary protein concentration and feeding rate on weight gain, feed efficiency, and body composition of channel catfish. In Experiment 1, two dietary protein concentrations (28% or 32%) and four feeding rates (≤ 90. ≤ 112, ≤ 135 kg/ha per d, or satiation) were used in a factorial arrangement. Channel catfish Ictalurus punctatus fingerlings (average size: 27 g/fish) were stocked into 0.04-ha ponds at a rate of 24,700 fish/ha. Fish were fed once daily at the predetermined maximum feeding rates for 282 d (two growing seasons). In Experiment 2, three dietary protein concentrations (24, 28, or 32%) and two feeding rates (≤ 135 kg/ha per d or satiation) were used. Channel catfish (average size: 373 g/fish) were stocked into 0.04-ha ponds at a rate of 17,300 fish/ha. Fish were fed once daily for 155 d. In both experiments, five ponds were used for each dietary treatment. Results from Experiment 1 showed no differences in total feed fed, feed consumption per fish, weight gain, feed conversion ratio (FCR), or survival between fish fed diets containing 28% and 32% protein diets. As maximum feeding rate increased, total feed fed, feed consumption per fish, and weight gain increased. There were no differences in total feed fed, feed consumption per fish, or weight gain between fish fed at ≤ 135 kg/ha per d and those fed to satiation. Fish fed the 28% protein diet had a lower percentage carcass dressout and higher percentage visceral fat than fish fed the 32% protein diet. Dietary protein concentrations of 28% or 32% had no effect on fillet protein, fat, moisture, and ash. Feeding rate did not affect FCR, survival, percentage carcass dressout, or fillet composition, except fillet fat. As feeding rate increased, percentage visceral fat increased. Fish fed at ≤ 90 kg/ha per d had a lower percentage fillet fat than fish fed at higher feeding rates. In Experiment 2, dietary protein concentration or maximum feeding rate did not affect total feed fed, feed consumption per fish, weight gain, FCR, or survival of channel catfish. Feeding rate had no effect on percentage carcass dressout and visceral fat, or fillet composition. This was due to the similar feed consumption by the fish fed at the two feeding rates. Fish fed the 24% protein diet had lower carcass dressout, higher visceral fat and fillet fat than those fed the 28% or 32% protein diet. Results from the present study indicate that both 28% and 32% protein diets provide satisfactory fish production, dressed yield, and body composition characteristics for pond-raised channel catfish fed a maximum rate of 90 kg/ha per d or ahove.  相似文献   

19.
–A dose titration study was conducted to determine the appropriate dosage of florfenicol in feed to control mortality in channel catfish Ictalurus punctatus associated with enteric septicemia of catfish caused by Edwardsiella ictaluri. Six tanks (20 fish/ tank) were assigned to each of the following treatment: 1) not challenged with E. ictaluri and fed unmedicated feed; 2) challenged with E. ictaluri and fed unmedicated feed; 3) challenged and fed 5-mg florfenicol/kg body weight (kg bw); 4) challenged and fed 10-mg florfenicol/kg bw; or 5) challenged and fed 15-mg florfenicol/kg bw. Treatment was initiated the day after inoculation, and feed was administered by hand at 2.5% body weight for 10 consecutive days. Feeding activity was scored for all groups and was noted to be significantly less than the challenged, unmedicated group. Cumulative mortality in the challenged untreated group was 60%. The mortality in the unchallenged untreated group was 0%, and in die 5-, 10-, 15-mg florfenicol/kg bw group was 2.5%, 0.8%, and 2.5%, respectively. The mortality in each challenged, treated group and the non-challenged control group was significantly less than the challenged, unmedicated controls (P < 0.0001 for each contrast). There were no pairwise statistically significant contrasts among the florfenicol treated groups and the non-challenged control group. All 600 fish in the study were necropsied, cultured for bacteria, and examined by gross pathology. No specific lesions that could be associated with the antibiotic were observed. The efficacy of the 10 mg/kg dosage was confirmed in a separate dose confirmation study. In this study, fish in 30 tanks (20 fish/ tank) were infected with E. icraluri by immersion. Two days post-inoculation, fish in 15 tanks were hand-fed unmedicated feed, and 15 tanks were hand-fed medicated feed at a dosage of 10-mg florfenicol/kg bw at 2.5% body weight for 10 d. Feeding activity was scored and was noted to be significantly less than the challenged, unmedicated group. Cumulative mortality in the florfenicol group (14%) was significantly less than cumulative mortality in the untreated group (87.3%) (P < 0.0001). All 600 fish were submitted for bacterial culture, necropsied. and examined for gross pathology, and once again, no specific lesions that could be associated with the antibiotic were observed. The minimum inhibitory concentration of florfenicol against E. ictaluri in both studies was 0.25 ug/mL. Florfenicol was palatable, safe, and efficacious for control of mortality due to infection by E. ictaluri in catfish.  相似文献   

20.
为了确定诺氟沙星在鲟养殖中的科学使用方法,对不同剂量、不同给药次数情况下诺氟沙星在西伯利亚鲟(Acipenser baerii)体内蓄积规律及毒性进行了研究。分别以0、30 mg/kg、50 mg/kg、100 mg/kg的剂量对西伯利亚鲟连续口灌诺氟沙星3~5 d,每天1次,并于停药后24 h及240 h采集实验鱼血、肝、肾及软骨组织,对4种组织中药物蓄积量进行测定,并对肝、肾和软骨组织进行切片观察。实验结果表明:随着给药剂量增加、给药次数增多,实验鱼4种组织中诺氟沙星浓度逐渐升高,浓度由高到低依次为为:肾、软骨、肝、血清,且血清中药物浓度远远低于另外3种组织。相同给药剂量、不同给药次数时血清中药物浓度无显著差异;而肝、肾和软骨中均差异显著,停药240 h后,显著性消失。切片结果表明,50 mg/kg剂量连续给药5 d后,实验鲟肝、肾组织开始结构损伤变化,100 mg/kg剂量连续给药3~5 d后,损伤情况持续加重,停药240 h后,肝组织损伤情况有逐渐恢复趋势,而肾组织未见明显恢复趋势;而100 mg/kg连续给药3~5 d后,软骨组织出现软骨膜内层细胞减少;停药240 h后有恢复趋势。研究结果表明,诺氟沙星在鲟中使用剂量应小于50 mg/kg,连续给药次数低于5次,以避免对鲟肝组织造成损伤,引起肾不可逆损伤及影响软骨细胞发育和再生,对软骨组织造成潜在影响。  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号